The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BSGM | +622.39% | -90.36% | -37.36% | -94% |
| S&P | +14.5% | +93.32% | +14.09% | +236% |
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Westport. CT.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.00M | -100.0% |
| Gross Profit | -$0.55M | -1438.9% |
| Gross Margin | -130.77% | 544.2% |
| Market Cap | $194.88M | 3841.7% |
| Market Cap / Employee | $38.98M | 0.0% |
| Employees | 5 | 25.0% |
| Net Income | -$20.37M | -420.8% |
| EBITDA | -$19.81M | -277.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $2.82M | 34.0% |
| Accounts Receivable | $0.00M | -100.0% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.00M | -100.0% |
| Short Term Debt | $0.02M | -94.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -46.44% | 454.7% |
| Return On Invested Capital | -364.47% | 201.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$1.28M | 13.7% |
| Operating Free Cash Flow | -$1.28M | 13.7% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | -850.00 | -61.14 | -24.67 | 66.46 | -7447.10% |
| Price to Sales | 141.24 | 642.16 | 480.68 | 15217.42 | 13360.82% |
| Price to Tangible Book Value | -18.03 | -36.46 | -14.71 | 73.99 | -8818.88% |
| Enterprise Value to EBITDA | -1.77 | -22.35 | -3.03 | -9.85 | 1730.24% |
| Return on Equity | -8041.7% | - | |||
| Total Debt | $0.15M | $0.10M | $0.06M | $0.02M | -94.68% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
